We have identified mutations in three different chromosomal genes of Escherichia coli K12 which reduce sensitivity to microcin B17. Mutations in ompF and ompR genes affected production of an outer membrane porin protein, OmpF, and resulted in reduced sensitivity to a number of other agents (colicins, bacteriophages) besides microcin B 17. The third class of mutants were specifically and highly resistant to microcin B17. The mutations in these strains were mapped to a gene (sbmA), located at 8.7 min on the E. coli K12 chromosome, which is closely linked to phoA. The wild-type sbmA allele was cloned into multiple copy number plasmids, and its location within the cloned DNA fragment was further defined by mutagenesis with MiniMudII 1681. These insertion mutations resulted in in-frame fusions between the sbmA and lac2 genes, thereby allowing us to determine the direction of sbmA gene transcription. Plasmids carrying these gene fusions produced low levels of P-galactosidase, indicating that the sbmA gene is poorly expressed. We have been unable to identify the sbmA gene product, but indirect evidence indicates that it might be an envelope protein involved in microcin uptake.
Identification, Mapping, Cloning and Characterization of a Gene (sbmA)
Required for Microcin B17 Action on Escheuichia coli K12 ~~~~ We have identified mutations in three different chromosomal genes of Escherichia coli K12 which reduce sensitivity to microcin B17. Mutations in ompF and ompR genes affected production of an outer membrane porin protein, OmpF, and resulted in reduced sensitivity to a number of other agents (colicins, bacteriophages) besides microcin B 17. The third class of mutants were specifically and highly resistant to microcin B17. The mutations in these strains were mapped to a gene (sbmA), located at 8.7 min on the E. coli K12 chromosome, which is closely linked to phoA. The wild-type sbmA allele was cloned into multiple copy number plasmids, and its location within the cloned DNA fragment was further defined by mutagenesis with MiniMudII 1681. These insertion mutations resulted in in-frame fusions between the sbmA and lac2 genes, thereby allowing us to determine the direction of sbmA gene transcription. Plasmids carrying these gene fusions produced low levels of P-galactosidase, indicating that the sbmA gene is poorly expressed. We have been unable to identify the sbmA gene product, but indirect evidence indicates that it might be an envelope protein involved in microcin uptake.
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I N T R O D U C T I O N
Microcin B 17 is a polypeptide antibiotic of approximately 4000 M , produced by Escherichia coli strains harbouring plasmid pMccBl7 (pRYC17) (Asensio et ul., 1976; Baquero et al., 1978; . The genetic determinants involved in microcin B17 production reside in a 3.8 kb stretch of plasmid DNA that contains four cistrons, all of which are required for antibiotic production (San Millan et al., 1985 a, b) . Microcin B 17 production also requires the expression of three chromosomal loci, one of which is the ompR gene (Hernandez-Chico et al., 1982; Baquero & Moreno, 1984) . Unlike the production of most colicins, that of microcin B17 is not lethal and is not induced by DNA-damaging agents (Baquero & Moreno, 1984; Pugsley, 1984) .
The activity spectrum of microcin B17 is restricted to a few species of bacteria related to E. coli. The antibiotic specifically inhibits DNA synthesis in susceptible E. coli K 12 strains; DNA is degraded, and the cells die. Consequently, the so-called SOS system is derepressed in microcin B17-treated cells. This expression requires the products of the recA and recBC genes and an active replication fork. Mutations in recA or recBC enhance microcin B17 sensitivity, whereas 1exA (Def) mutations reduce it .
As another approach to the study of microcin B 17 action, we have isolated and characterized microcin B17 insensitive mutants of E. coli K 12. In this article, we identify three chromosomal genes whose products are required for microcin action, and report the cloning and characterization of one of them which seems to be specifically involved in microcin action.
Abbreviations : B I 7R, microcin B 17 resistance; XP, 5-bromo-4-chloro-3-indolylphosphate ; X-gal, 5-bromo-4-chloro-3-indolyl [h-galactoside; AU, arbitrary antibiotic unit; IPTG, isopropyl-P-D-galactopyranoside.
METHODS
Bacterial strains, pfasmids and bacteriophages. Those used are listed in Table 1 . Media and chemicals. LB medium and M63 minimal medium (Miller, 1972) were used throughout. M63 medium was supplemented with thiamin (1 pg ml-I ), glucose (0.2%) or lactose (0.273, and, where necessary, with L-amino acids (20 pg ml-l). Antibiotics were used at the following concentrations: ampicillin (Ap), 50 pg ml-l; tetracycline (Tc), 20 pg ml-I ; streptomycin (Sm), 100 pg ml-I ; sodium nalidixate (Nal), 40 pg ml-I ; kanamycin (Km), 30 pg ml-I. Phage P1 was grown on LB agar supplemented with 2.5 mM-CaC1ZY 0.2% glucose and 1.2% Difco agar. Alkaline phosphatase-producing (PhoA+) strains were scored on MOPS/glucose medium supplemented with 10-4 M-potassium phosphate (Neidhardt et af., 1974) and containing 40 pg XP (5-bromo-4-chloro-3-indolylphosphate) ml-1 as chromogenic alkaline phosphatase substrate. Production of P-galactosidase (LacZ+) was detected on LB agar plates containing 20 pg X-gal(5-bromo-~~-chloro-3-indolyl &D-galactoside) ml-' (Miller, 1972) . Microcin insensitive mutants were selected on M63 glucose or LB agar plates containing crude microcin (50 AU ml-I). Microcin was prepared using the overproducing strain RYC893 and assayed as described below.
Microcin, coficin and phage sensitiuity. Microcin B17 sensitivity was determined by allowing drops of a suspension of strain RYC893 to run in a straight line on M63 glucose plates. After 30 h incubation, strains to be tested were cross-streaked and the plates reincubated. Only resistant clones grew in the vicinity of the microcinogenic bacteria. The critical dilution method (Mayr-Harting et af., 1972) was used for more accurate determinations of microcin sensitivity. Colicin sensitivity was also determined by the cross streak method using the strains listed by Pugsley (1985) . Phage sensitivity was determined by cross-streaking using phages TuIa (5 x lo7 p.f.u. ml-l) and 1Vh434 (1 x lo8 p.f.u. ml-I).
Transposon Tn5 rnutagenesis, Five cultures of strain BM21 were incubated at 30 "C with phage A467 (rex : :Tn5) according to Berg (1977) . After 20 min, the mixture was diluted into 9 vols L broth and incubated for 2 h at 42 "C to allow expression of kanamycin resistance. Samples from each culture were then plated on M63 glucose medium containing Km and microcin B17, and incubated at 42 "C.
Genetic techniques. Conjugation and P1 transduction were done as described by Miller (1972) . Plasmid DNA was extracted from overnight LB cultures. Cleared lysates were obtained and DNA was precipitated as described by Maniatis et af. (1982) . Digestion with restriction endonucleases, ligation with T4 DNA ligase and transformation were all done as described by Davis et al. (1980) . Agarose gel electrophoresis was done in a vertical slab apparatus using Tris/phosphate buffer (Davis et af., 1980) . Tlie sizes of restriction endonuclease fragments were determined by comparing their mob es with Hind111 fragments of phage A DNA (Sanger et a/., 1982) or with HaeIII fragments of phage 4x174 replicative DNA (Sanger et al., 1978) in 0-6-1*2% agarose gels.
Construction of'pMM100. The expression vector pUC13 (Messing, 1983 ) was used to clone sbmA+ under lacZp control. In order to avoid problems caused by the poor growth of cells carrying this pUC13 derivative, we first constructed a compatible, multiple copy number plasmid carrying the fa&' allele of the lactose repressor gene (Calos & Miller, 1981) . An EcoRI fragment of pLi7 (Table 1) containing faclql was extracted from an agarose gel and ligated into the EcoRI site of pACYC184. The resulting plasmid, pMM100, was shown to repress fa&+ expression in cells devoid of the chromosomal facl gene. facZ expression remained inducible by IPTG.
sbmA : :MudZZI68I gene jksions in pMM73-4. Strain POII1681(pMM73-4) was used to produce transducing particles. These were used to infect strain RYC761 as described by Castilho et af. (1984) . The transduction mixture was incubated for 3 h at 30 "C to allow expression of kanamycin resistance, and was then plated onto LB Km Tc X-gal agar containing microcin B17. Nine experiments were done in order to obtain independent insertions. P-Galactosidase was assayed according to Miller (1 972) .
RESULTS
Isolation of microcin BI 7-resistant mutants. Spontaneous resistant mutants were obtained at frequencies of about 1 x when sensitive E. coli K12 BM21 or RYC10 cells were plated on selective agar containing microcin B17. The mutants appeared at about 10 times this frequency when Tn5-mutagenized bacteria were used.
Mutations in ompR and ompF cause microcin resistance. Mutants obtained by the above procedure were tested for their sensitivity to various bacteriophages and colicins. A small proportion were resistant to bacteriophage TuIa or TuIa plus AVh434, and exhibited substantially reduced sensitivity to colicins A, E2 through E8, K, L, S4 and N. An examination of their outer membrane protein profiles by SDS-PAGE revealed that they were devoid of major outer membrane proteins OmpF (TuIaR, AVh434s) or OmpF plus OmpC (TuIaR, AVh434R), which agrees with the fact that these phages use OmpF or OmpC respectively as their receptors 7 SpR, spectinomycin resistant.
$ The recA56 allele was introduced into several strains by contransduction with sr1::TnlO using P1 grown on strain RYC816. TcR transductants were selected, and RecA-clones were detected by their increased sensitivity to UV light. Q Tn5 confers kanamycin resistance. (Datta et al., 1977; Hankte, 1978) . Mutations which reduce production of OmpF or OmpF plus OmpC proteins are also known to cause reduced sensitivity to several colicins (Pugsley, 1984) . Mutations in two different genes are known to produce the phenotype(s) we have described above for the microcin resistant mutants : mutations in ompF, the structural gene for the OmpF protein, cause specific loss of OmpF, whereas mutations in ompR, a positive regulator gene, often result in failure to produce OmpF and OmpC proteins (Mall & Silhavy, 1981) . The genetic location of two of each class of mutations selected by their microcin B17 resistance phenotype was confirmed as ompF or ompR by P1 transduction experiments. The TuIaR B 1 7R (microcin B17 resistance) mutation was 50% cotransduced with pyrD (21 min), and the TuIaR B17R AVh434R mutation was 80% cotransduced with malA (75 min). These are the expected linkages for ompF and ompR loci respectively (Bachmann, 1983) . In addition, well-characterized mutations in ompR and in ompF were also found to confer microcin B 17 resistance (see Table 4 ).
Mutants speciJically resistant to microcin B27. Approximately 80% of the mutants we obtained were specifically resistant to microcin B17, and remained sensitive to all other agents tested. We first studied mutants of this type obtained after transposon Tn5 mutagenesis. Absolute linkage of Tn5-encoded kanamycin resistance and microcin B 17 resistance was first tested by P1 phage transduction, thereby confirming that Tn5 was inserted in the gene required for microcin sensitivity. One such strain used for further analysis was RYC714, and the locus affected was termed sbmA (sensitivity to B17 microcin). The sbmAI2: :Tn5 mutation was transduced into strain pop3000 (HfrH), which was then conjugated with strain RYC22 (Thr-Leu-ProALacy-Tsx-NalR) with selection for KmR and counter selection for NalR (GyrA-) . This experiment demonstrated a close linkage between sbrnAII : :Tn5 and lacy. The results of P1 transduction experiments reported in Table 2 confirmed this linkage, and showed that the sbrnA22 : : Tn.5 mutation was 90% cotransduced with the proC gene being located between this marker and lac. Other transduction experiments showed that the spontaneous sbmA2 mutation was also cotransduced with proC (86%) and was located to the left of phoA (Table 3 ). All these data indicate that sbmA maps at approximately 8.7 min on the E. coli linkage map with the following order of markers : lac-sbmA-phoA-proC.
Several other independent Tn5 and spontaneous microcin B 17-resistant mutants were also analysed by P1 transduction to localize their mutations. They all showed high cotransduction (85-90%) with proC. In addition, a significant proportion of mutants were also unable to produce alkaline phosphatase on XP plates, indicating that they probably carried deletion mutations affecting sbmA andphoA. We conclude that all these mutants are affected in the same locus, sbmA.
Two F' factors (F'W 3747 and X573 ; Low, 1972) carrying the 8-9 min region of the E. cofi K 12 chromosome were introduced into strain RYC760 (SbmA-PhoA-Lac-RecA-). They complemented the sbmA mutation, and the normal level of microcin B17 sensitivity was recovered. The sbmA mutation is, therefore, recessive to the wild-type allele.
Levels ojmicrocin B17 resistance. Strains carrying recA mutations are about 10 times more sensitive to microcin B17 than strains with the recA+ allele . The critical dilution method was used to evaluate the level of microcin B17 resistance afforded by ompF, ompC, ompR and sbmA mutations in strains also carrying r e d + or recA alleles. Strains carrying ompR or ompF mutations were only partially resistant to microcin B17, whereas strains carrying the sbmA mutation were completely resistant. ompC mutations resulted in a slightly decreased sensitivity (Table 4) .
Cfoning ojsbmA into pBR322. Plasmid pL7 19, from the Clarke and Carbon collection (Clarke & Carbon, 1976) , carries the phoA+, proC+ and phoB+ alleles (R. Portalier, personal communication), and was found to complement sbmA mutations. It was transferred by Fduction to strain RYC953 (SbmA-ProC-), with selection on minimal medium without proline. All but one of the transconjugants were microcin B17 sensitive and synthesized alkaline phosphatase. The plasmid from the microcin B 17-resistant clone was purified and analysed with restriction endonucleases. It was found to lack a 6-8 kb stretch of DNA from within an 8.8 kb PstI fragment of pL719. This fragment was cloned into the PstI site of pBR322. Strain RYC953 was transformed with a ligation mixture containing PstI digests from pL719 and pBR322, and TcR clones were selected. Plasmid pMM70 was found in one of the TcR transformants which was sensitive to Ap and microcin B17. This plasmid carried both phoA+ and sbmA+ alleles. A physical map of pMM70 is presented in Fig. 1 .
To localize the sbmA locus on pMM70, we constructed a series of in vitro deletion derivatives. All but one of them, pMM73-3, complemented chromosomal sbmA mutations, indicating that sbmA is located within the 2.6 kb A d -P s t I fragment of pMM70 (Fig. 1). lac2 gene fusions in sbmA. In order to determine the direction of sbmA transcription, we constructed sbmA-lac2 gene protein fusions in plasmid pMM73-4 using miniMudII 168 1 (Castilho et al., 1984) . Plasmid pMM73-4 was introduced into strain POII1681, and a phage lysate was obtained from the resulting transformant. Strain RYC761 A(phoA sbmA) was transduced with the lysate in nine separate experiments. Transductants which had received pMM73-4 (TcR) and Mud111681 (KmR) and which retained their microcin B17 resistance were selected on M63 glucose X-gal plates supplemented as indicated in Methods. Approximately 17% of the transductants were Lac+ and, therefore, likely to carry sbmA-lac2 gene fusions created by insertion of Mud111681 into sbmA. Nine independent Lac+ clones were selected for further analysis. Each contained a plasmid of about 22.4 kb (comprising the 8.2 kb of pMM73-4 and the 14-2 kb of MudII1681) which could transform L a d -strains to Lac+, but which could not complement sbmA mutations. These plasmids were digested with PstI and BamHI restriction endonucleases in order to determine the orientation and position of the Mud11168 1 insertions (Fig. 2) . All of the insertions were within a 1050 bp length of DNA within the PstIBglII fragment of pMM73-4. They were all orientated in the same direction, with lac2 being read from the PstI end of the fragment towards the BglII end. By relating these results to the known positions of phoA and sbmA in pMM70 and in the E. coli K12 chromosome (Fig. 1)  (Bachmann, 1983) , we can deduce that sbmA is transcribed in a clockwise direction in the E. coli chromosome .
/?-Galactosidase activities in strains carrying plasmids with sbmA-lac2 gene fusions were relatively low (Fig. 2) .
Cloning of'sbmA in pUCZ3. We have studied the protein profiles of cell envelope and soluble fractions from strains carrying wild-type or mutant sbmA alleles, and from strains carrying pMM70 and its deletion derivatives, by SDS-PAGE, but have consistently failed to identify any protein which could correspond to the sbmA gene product. The presence of pMM70 and its SbmA+ derivatives did not increase sensitivity to microcin B17, suggesting that either the sbmA gene product was not overproduced or it was not limiting for microcin B 17 action. In order to increase SbmA production, we cloned the 1.75 kb Pstl-BglII fragment of pMM73-4 into pUC13 in the hope of expressing sbmA from the lac2 promoter. Transformants carrying this recombinant plasmid (pMM90) were indeed about four times more sensitive to microcin B17 than wild-type cells, suggesting that an increase in the level of sbmA gene expression had been achieved. However, we were still unable to detect a putative sbmA gene product. All these experiments were done in cells carrying pMM100, a multiple copy number plasmid carrying the lacIq] repressor allele, and in the absence of induction by IPTG. Clones carrying pMM90 in the absence of lad-encoded repressor, or even in the presence of pAPIP502 ( F lacql), were unstable, grew poorly and tended to produce microcin-resistant subclones. IPTG induction of cells carrying pMM9O and pMMlOO also caused a rapid loss of viability. We conclude that overexpression of sbmA may be lethal.
DISCUSSION
Mutations in three chromosomal genes, ompF, ompR and the previously undescribed gene which we have named sbmA, affect sensitivity to microcin B17. If we consider that sbmA constitutes a single cistron, it could encode a protein of 2 40 kDa. Experiments with sbmA-lac2 gene fusions indicate that sbmA is probably poorly expressed, which is consistent with the fact that we have so far been unable to detect the sbmA gene product, either by examining fractionated cells by SDS-PAGE, or by labelling plasmid-encoded proteins in maxicell or minicell systems (data not shown).
The results we have obtained do not allow us to define the roles of the ompF, ompR and sbmA gene products in microcin B17 action. It is possible that OmpF protein plays a role in the penetration of the E. coli K12 outer membrane by microcin B17, as it does for several colicins (Konisky, 1979; Pugsley, 1984) . Our results show that OmpC protein is only partially able to replace OmpF protein with respect to microcin B17 action, as is the case with colicins such as E2 and E3 (Mock & Pugsley, 1982) . These major outer membrane proteins may either function as pores to allow the passage of the microcin/colicin across the membrane, or may help to stabilize or activate the microcin/colicin receptor. The former hypothesis seems more likely in the case of microcin B17 than for colicins such as E2 or E3, because microcins are considerably smaller (Baquero & Moreno, 1984) .
The role of the sbmA gene product in microcin B17 action remains to be defined. Mutations affecting sbmA, and even deletions of the entire gene, do not affect cell growth, indicating that the sbmA product is not essential for cell viability. The fact that sbmA mutations lead to very high levels of microcin B17 resistance indicates that it codes for a key product for microcin action. The following results indicate that the sbmA gene may code for, or is required for, the synthesis of an envelope protein, possibly the microcin B17 receptor. (a) Exogenous microcin B17 kills susceptible bacteria, and induces genes involved in the SOS repair system in susceptible and immune strains . These effects are not observed~ in sbmA mutants. (6) Microcin-producing cells exhibit levels of SOS gene expression (measured with a s$A-lacZ operon fusion) which are higher than those in cells without plasmids or in cells harbouring non-producing plasmid derivatives. When cells carried the wild-type plasmid pMccB17, in which microcin production is balanced with immunity, the level of cD(sJA-lacZ) expression was twice the basal level. This stimulation in SOS expression was completely abolished when the producer cells carried the sbmAI mutation (Herrero ef al., 1986) . A similar situation has been described previously with cells carrying plasmids encoding colicin E2, which has endodeoxyribonuclease activity, and hence induces the SOS system. Mutations affecting colicin E2 uptake (btuB or ompF/ompR) in the colicin producer cells eliminated the SOS stimulation effect. It was concluded that the effect was due to colicin, which, after being released into the medium, entered other cells in the culture, overcoming their immunity and thus exerting its effects (Pugsley, 1983; Pugsley et al., 1983) . (c) When cells harboured pMM102, a plasmid in which the balance between microcin production and immunity was altered, during its construction, in favour of production (unpublished), @(sJAIacZ) was expressed at levels as high as 15 times the basal value (Herrero, 1984) . In this case, the introduction of the sbmA I mutation reduced, but did not abolish, the activation of @(s$A-lad), which was expressed at four times the basal level (Herrero, 1984) . These results indicate that sbmAI did not prevent the action of endogenous microcin that had not been neutralized because of the inbalance between production and immunity. ( d ) Further support for this view came from the behaviour of strains carrying pMM102 and a recA mutation. As indicated in the Introduction, recA and recBC mutants are extremely sensitive to microcin. When these cells carry pMM102 they cannot grow in minimal medium in which microcin production is 'optimal'. This property, which is due to the inbalance between production and immunity (San Millkn et al., 1985a; unpublished) , could neither be suppressed by the introduction of sbmA mutations, nor by ompR mutations. Hence these mutations protect cells from exogenous, but not from endogenous, microcin. We are, at present, attempting to select chromosomal mutations which prevent the action of endogenous microcin B17.
In conclusion, our results indicate that sbmA mutants remain sensitive to microcin produced by and acting within the producer cell. The product of the sbmA gene is therefore needed only for the action of exogenous microcin, and hence is likely to play a role in microcin uptake. The preparation of radio-labelled microcin for use in binding assays will be required to demonstrate whether the sbmA product is indeed the microcin B17 receptor. The low level of microcin activity so far recovered, even from cultures of overproducing strains, is insufficient for this purpose.
